Survival benefit of multidisciplinary care in amyotrophic lateral sclerosis in Spain: association with noninvasive mechanical ventilation by Paipa, Andres Julian et al.
OR I G I N A L R E S E A R C H
Survival benefit of multidisciplinary care in
amyotrophic lateral sclerosis in Spain: association
with noninvasive mechanical ventilation
This article was published in the following Dove Press journal:













Hospital de Bellvitge, Hospitalet de
Llobregat, Barcelona, Spain; 2Research
Group on Statistics, Econometrics and
Health (GRECS), University of Girona,
Girona, Spain; 3Endocrinology and
Nutrition Department, IDIBELL-Hospital
de Bellvitge, Hospitalet de Llobregat,
Barcelona, Spain; 4Internal Medicine
Department, IDIBELL-Hospital de
Bellvitge, Hospitalet de Llobregat,
Barcelona, Spain; 5Faculty of Medicine
and Health Sciences, Universitat
Internacional de Catalunya, Barcelona,
Spain
*These authors contributed equally to
this work
Purpose: Multidisciplinary care has become the preferred model of care for patients with
amyotrophic lateral sclerosis (ALS). It is assumed that the sum of interventions associated with
this approach has a positive effect on survival. The objective of the study was to evaluate the
impact of a multidisciplinary care approach on the survival of patients with ALS.
Patients and methods: We performed a retrospective review of prospectively collected
data in a tertiary referral center in Spain. Participants were patients with definite or probable
ALS managed in a multidisciplinary care program. We compared demographic and survival
data of patients with definite or probable ALS treated in a referral center without and with
implementation of a multidisciplinary care program. We performed time-dependent multi-
variate survival analysis of the use of noninvasive mechanical ventilation (NIMV) and
gastrostomy.
Results: We evaluated 398 consecutive patients, of whom 54 were treated by a general
neurologist and 344 were treated in the multidisciplinary care clinic. Patients receiving
multidisciplinary care were older (62 vs 58 years), tended to have bulbar onset disease
(30% vs 17.7%), and were more likely to receive riluzole (88.7% vs 29.6%, p<0.01), NIMV
(48.8% vs 29.6%, p>0.001), and nutrition via gastrostomy (32.3% vs 3.7%, p<0.01).
Kaplan–Meier analysis showed a 6-month increase in survival (log-rank, 16.03, p<0.001).
Application of the Andersen-Gill model showed that the variables associated with reduced
mortality were reduced time to NIMV and gastrostomy and the duration of both, thus
reflecting compliance.
Conclusions: Multidisciplinary care increased the survival of ALS patients in our study
population. Timely use of respiratory support and gastrostomy are fundamental aspects of
this benefit.
Keywords: ALS, survival, multidisciplinary care, noninvasive mechanical ventilation,
gastrostomy
Introduction
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder characterized by
progressive loss of neurons. It affects the corticospinal tract, brainstem, and anterior
horn cells of the spinal cord, leading to loss of bulbar and limb function and
respiratory muscle weakness.1 Mean life expectancy is 3–5 years, although this
varies considerably, with up to 10% of patients living longer than 10 years.2
Despite numerous clinical trials, riluzole continues to be the only approved
pharmacological agent and has been shown to prolong survival by around 38% at
18 months.3 Therefore, treatment of ALS is aimed at relieving symptoms and
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improving quality of life (QoL). Multidisciplinary care is
the standard approach recommended by guidelines from
Europe4 and the US.5 This approach was first shown to
improve survival in Ireland,6 with subsequent reports from
Italy7 and England,8 all of which pointed to an association
between increased use of riluzole, gastrostomy, and non-
invasive mechanical ventilation (NIMV) and longer survi-
val. There is also evidence that multidisciplinary care
improves QoL.9 However, not all reports have shown
a positive effect. A study from southern Italy showed no
improved survival in a cohort of patients treated based on
a multidisciplinary approach in whom the use of gastro-
stomy and NIMV was infrequent.10 Furthermore, survival
studies have been criticized because patients referred for
multidisciplinary care are young and therefore have good
survival prospects.11
We describe our experience with the implementation of
a program for the multidisciplinary care of ALS patients at
a referral center in Spain. We also evaluated clinical vari-
ables associated with prognosis, focusing on the impact of
NIMV and duration of gastrostomy tube placement on
survival.
Materials and methods
The ALS Multidisciplinary Care Clinic at Hospital
Universitari de Bellvitge, L’Hospitalet de Llobregat,
Spain was established in 2001 to ensure delivery of con-
tinuing care through a dedicated team of specialists (neu-
rologist, pulmonologist, nutritionist, endocrinologist,
rehabilitation specialist, physical therapist, psychologist,
social worker, nurse manager, speech therapist, and an
administrative worker). Patients were seen every 3
months, with each visit including assessment of pulmonary
function (forced spirometry; home nocturnal pulse oxime-
try; and arterial blood gas levels) and nutritional status,
with early NIMV and placement of a gastrostomy tube
advocated as stated in the guidelines of the American
Academy of Neurology and the European Federation of
Neurological Societies.4,5
From January 2001 to December 2012, we prospec-
tively collected the following data from each new patient
with probable or definite ALS admitted to the clinic:
symptom onset, date of diagnosis, type of onset (bulbar,
spinal, respiratory), and demographic characteristics. In
addition, we retrospectively reviewed our local database
and the hospital records of 54 patients seen by
a neuromuscular neurologist during the previous 10 years
(1991–2000) and who met the criteria for probable or
definite ALS. We recorded family history of ALS and
the diagnostic delay from symptom onset, as these are
well-established prognostic factors.12 Survival was mea-
sured in months from symptom onset. In order to ensure
comparability between the groups and exclude historic
control long-term survivors who may have been seen at
the clinic later in the course of their disease, we excluded
those controls whose period from symptom onset to death
overlapped with implementation of multidisciplinary care.
We also reviewed each file individually and excluded
patients with atypical motor neuron disease phenotypes
(primary lateral sclerosis, primary muscular atrophy, flail
arm syndrome, flail leg syndrome, Kennedy disease), as
these patients are long-term survivors within the motor
neuron disease spectrum. Follow-up was managed using
the registry of the ALS patients’ association (Fundación
Miquel Valls) and review of centralized primary care
information.
Statistical analysis
We report the demographic and clinical characteristics of
both groups as means for age (with range or standard devia-
tion values, as appropriate) and as percentages for categorical
variables. Normally distributed continuous variables were
compared using the t test; non-normally distributed variables
were compared using the Mann–Whitney test. Proportions
were compared using χ2 test. Survival curves were con-
structed using the Kalbfleisch–Prentice method,13 which is
equivalent to the Kaplan–Meier estimates when the weights
are unity (as in our case). Survival curves were compared
using the log-rank test.14 Multivariate analyses were per-
formed using the Andersen–Gill model.15–17 Explanatory
variables included age, sex, site of onset, family history, use
of riluzole, NIMV, gastrostomy, and treatment at the multi-
disciplinary care clinic. Explanatory variables in the risk of
progression of ALS that are time-dependent include time on
NIMVand duration of gastrostomy tube placement. Risks are
therefore not proportional and violate themain assumption of
the Cox proportional hazard risks model. For this reason, and
in order to obtain consistent estimates, the Andersen–Gill
model was used, allowing for the evaluation of time-
dependent variables that could account for the risk of pro-
gression of ALS.
To further explore how multidisciplinary care affected
survival, we calculated time from symptom onset to NIMV
and gastrostomy, as well as the time each patient received
NIMV, and used gastrostomy as a measure of tolerance and
compliance. The descriptive analysis, Kalbfleisch–Prentice
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estimation of the survival curves, and the log-rank test were
performed using IBM SPSS Statistics for Windows, version
21.0. The multivariate analyses were carried out in the free
statistical software environment R, version 3.2.1. A value of
p>0.05 was deemed statistically significant, and comparative
tests were two-tailed.
Results
We prospectively followed up 334 ALS patients in our multi-
disciplinary care clinic from January 2001 to December 2012.
Demographic data are shown in Table 1. As expected, therewas
a predominance of men, who were slightly overrepresented in
the historic control patients (64.8% vs 53.6%, p=0.14). Patients
treated in the clinic were older (62 vs 58 years, p=0.01), with
a trend toward a more frequent bulbar onset, although without
reaching statistical significance (30.9 vs 17.7%, p=0.35).
Patients treated in the clinic were more likely to receive inter-
ventions such as riluzole (88.7% vs 30.6%, p<0.001), NIMV
(47.8% vs 14.5%, p<0.001), and gastrostomy (32.9% vs 3.2%,
p<0.001). In patients receiving NIMV, multidisciplinary care
was associated with a significant shortening of the time to
NIMV (14 vs 25 months, p<0.001). Patients in the historic
cohort had a 2-month shorter mean diagnostic delay (8 vs 10
months, p=0.15).
Survival analyses
A total of 276 patients (30.7%) died during follow-up.
Median survival time was 34 months (95% CI, 27–41)
for the historic cohort and 40 months (95% CI, 35–45)
for those treated under the multidisciplinary care model.
This difference was statistically significant (log-rank,
p<0.001). The increase in survival was greater in patients
with bulbar onset disease, where survival increased by 10
months (24 vs 34 months; log-rank, 9.07; p=0.003).
Application of the Andersen–Gill models showed that bul-
bar onset and older age were associated with a poorer prog-
nosis, while the use of riluzole was protective (Table 2). In this
model, multidisciplinary care showed a nonsignificant trend
toward a protective effect (HR, 0.37; 95% CI, 0.034–4.08;
p=0.41). None of the other therapeutic interventions were asso-
ciated with reduced mortality. However, when time of gastro-
stomy and NIMV were included in the model as time-
dependent covariables, we found that the use of both interven-
tions was directly associated with reduced mortality (Table 3).
Likewise, the time from symptom onset to NIMVand gastro-
stomy were independent protective factors, with each month of
NIMVrepresenting a 6% decrease in mortality hazard and each
month of gastrostomy representing a 3% decrease.
Discussion
Over the past two decades, multidisciplinary care has become
the preferred model of care for ALS patients worldwide.
Centralization in tertiary care centers provides several advan-
tages for both patients and the ALS research community.
A multidisciplinary approach allows concentration of care-
giver expertise in an infrequent disease, better communication
between teammembers (thus facilitating decision-making and
planned advanced directives, faster and timely access to inter-
ventions [pharmacological, nutritional, respiratory, and phy-
siotherapeutic]), and easier access to research and clinical






Age at onset in years (range) 58 (30–77) 62 (24–87) 0.01
Gender M: 35 (64.8%) M: 183 (53.6%) 0.14
Type of onset
Spinal 41 (75.9%) 229 (66.65%) 0.35
Bulbar 11 (20.4%) 103 (29.9%)
Respiratory 2 (3.7%) 12 (3.5%)
Riluzole 16 (29.6%) 305 (88.7%) <0.001
NIMV 7 (13%) 168 (48.8%) <0.001
Gastrostomy 2 (3.7%) 111 (32.3%) <0.001
Family history 2 (3.2%) 4 (1.1%) 0.20
Time to NIMV (months) 25 14 <0.001
Diagnostic delay (months) 8 10 0.15
Abbreviation: NIMV, noninvasive mechanical ventilation.
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trials. Although a cumulative body of evidence shows that
multidisciplinary care results in increased patient life span,18,19
the factor accountingmost for this increase in survival remains
unknown. Some initial reports suggested that this may be due
to referral bias,9 although more recent population-based
research in Ireland has consistently demonstrated that multi-
disciplinary care confers a survival advantage that is indepen-
dent of age in patients with ALS.20
To the best of our knowledge, this is the first study to
evaluate the effect of a multidisciplinary care model in
Spain. Our study provides further evidence for increased
survival in the multidisciplinary care clinic compared with
a general neurology practice. Patients with bulbar disease
are those who most benefit from a multidisciplinary
approach. In our center, patients receiving multidisciplinary
care were more likely to receive interventions destined to
increase survival. Given that use of riluzole,3 NIMV,21 and
nutritional support have all been associated with increased
survival, it is difficult to establish the role of each interven-
tion on the observed effect.
The effect of compliance with NIMV has been asso-
ciated with improved survival in the context of multidisci-
plinary care.22 The Andersen–Gill model better reflects the
effect of time-dependent variables on survival, as it pro-
vides data from discontinuous intervals of risk. Using this
model, we were able to establish a relationship between
a reduced time from symptom onset to NIMV and gastro-
stomy and improved survival. However, it is important to
remember that procedures were often undertaken later than
necessary. This is not surprising, given that the control
cohort includes patients who were diagnosed 20–30 years
ago. The model also allowed us to include duration of
NIMV and gastrostomy tube placement as variables,
which in both cases revealed a protective effect. We
hypothesize that the extent of this period reflects factors
such as improved tolerability, patient compliance, and
caregiver support. In fact, when included in the model,
adherence to NIMV and gastrostomy remain protective.
However, the need for gastrostomy or NIMV, which reflect
an aggressive later-stage approach in patients with early
bulbar disease or respiratory onset, is associated with
a poorer prognosis.
Use of historic controls allowed us to better reflect the
impact of multidisciplinary care on patients with ALS,
although it also highlighted limitations, since these only
reflect the practice of a single neurologist. In addition,
their retrospective nature makes it impossible to control
for unknown variables, and the fact that the patients were
from different time periods could generate bias resulting
from changes in management protocols. There is also the
presence of collinearity in the time-dependent variables,
because controls less frequently received NIMV and gas-
trostomy. We strongly believe that time-dependent vari-
ables should be included in future prospective analyses:
our results provide evidence that they significantly affect
the survival of ALS patients receiving multidisciplinary
care. In contrast with other studies, patients attending the
multidisciplinary unit were not necessarily younger. In
addition, the impact of age on survival is greater in
patients with bulbar involvement, most likely owing to
the early management of dysphagia-associated complica-
tions. Even so, analysis of the impact of the unit does not
reveal variations, probably because the disease has
a poorer prognosis in these patients. Our results are also
limited by the fact that we were unable to include cogni-
tive impairment as a prognostic variable, since





ALS Unit 0.88 0.07–10.12 0.92
Gender 0.90 0.86–1.42 0.42
Bulbar onset 2.43 1.24–4.77 0.01
Family history 1.54 0.59–3.98 0.37
Riluzole 0.82 0.44–0.92 0.01
NIMV 2.7 1.94–3.8 0.12
Gastrostomy 1.83 1.29–2.58 <0.001
Age (years) 1.02 1.01–1.03 <0.001
Diagnostic delay (months) 0.99 0.99–1.0 0.71
Time of NIMV use (months) 0.94 0.93–0.94 <0.001
Time of gastrostomy use (months) 0.97 0.95–0.98 <0.001
Abbreviation: NIMV, noninvasive mechanical ventilation.




ALS unit 0.37 0.034–4.08 0.41
Gender 0.98 0.76–1.27 0.91
Bulbar onset 1.07 0.78–1.46 0.67
Family history 0.44 0.84–5.91 0.1
Riluzole 0.57 0.44–0.92 0.01
NIMV 0.8 0.94–1.63 0.12
Gastrostomy 0.78 0.94–1.7 0.11
Age (years) 1.02 1.01–1.03 <0.001
Diagnostic delay (months) 1.01 0.98–1.01 0.14
Abbreviation: NIMV, noninvasive mechanical ventilation.
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a neuropsychological evaluation was not systematically
performed at the time. The limitations of this study could
be improved by performing studies with larger numbers of
patients and, therefore, larger databases.
Possible advantages of the multidisciplinary care
approach not assessed in this cohort include psychosocial
advantages in terms of communication with primary care
teams, caregiver support, reduced hospital admissions, and
earlier referral for palliative care. We believe these interven-
tions might have an added effect on the survival of ALS
patients and should be studied prospectively.
Conclusion
Implementation of multidisciplinary care resulted in
improved survival in our ALS population. Timely use of
NIMV and gastrostomy and compliance with interventions
are fundamental aspects of this benefit and deserve evalua-
tion in further prospective studies.
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